Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) — The “Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies” report has been added to ResearchAndMarkets.com’s offering. The publisher’s research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGTContinue Reading
DUBLIN–(BUSINESS WIRE)–The “Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies” report has been added to ResearchAndMarkets.com’s offering. The publisher’s research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, thereContinue Reading
LONG BEACH, Calif.–(BUSINESS WIRE)–Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or the “Company”), a global leader in launch services and space systems, today announced that it completed its previously announced merger with Vector Acquisition Corporation (Nasdaq: VACQ) (“Vector”) to take Rocket Lab public. Vector’s shareholders approved the merger atContinue Reading
The causative agent of the coronavirus disease 2019 (COVID-19) – severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – was first detected in Wuhan, China, in December 2019. To date, the virus has spread to over 192 countries and territories, infected over 173.6 million people and caused over 3.7 million deaths.Continue Reading
